Pamela Krueger Regeneron · Therapeutic Proteins
Pamela Krueger - Director, Research Pharmacokinetics - Regeneron
Director, Research Pharmacokinetics at Regeneron Pharmaceuticals, Inc. · Experience: Regeneron · Education: Rutgers, The State University of New Jersey-New ...
Pamela Krueger Regeneron · Therapeutic Proteins - ResearchGate
Recombinant IL-2 has been used for the treatment of metastatic melanoma and renal cell carcinoma, and induced complete, durable tumor regression in some ...
Pamela Krueger (0000-0002-6166-7189) - ORCID
Regeneron Pharmaceuticals Inc: Tarrytown, NY, US. 2004 to present | Associate Director, Research PK (Therapeutic Proteins). Employment. Show more detail. Source ...
Kappa-on-Heavy (KoH) bodies are a distinct class of fully ... - PNAS
We also thank the Velocigene, Protein Expression Sciences, Vivarium, Therapeutic Proteins, Cardiovascular, and Program Management departments at ...
A PD-1-targeted, receptor-masked IL-2 immunocytokine ... - PubMed
... Pamela Krueger , Christina Adler , Min ... Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA. ... We develop a programmed cell death protein ...
A PD-1-targeted, receptor-masked IL-2 immunocytokine that ...
The clinical use of interleukin-2 (IL-2) for cancer immunotherapy is limited by severe toxicity. Emerging IL-2 therapies with reduced IL-2 ...
Pamela Krueger on LinkedIn: Director Synthetic Chemistry
We are seeking a motivated scientist to join Bioanalytical and Biomarker group at Regeneron, to apply qualitative and quantitative mass ...
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human ...
Pamela Krueger , Ashique Rafique , Naxin ... Regeneron Tech Centers, Regeneron Pharmaceuticals ... Protein Conformation. Substances.
Combinatorial Inhibition of Myostatin and Activin A Improves ... - Wiley
Sandra Kleiner, an employee and stock owner of Regeneron Pharmaceuticals Inc. Ashique Rafique and Pamela Krueger are employees of Regeneron ...
A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor ...
Pamela Krueger;. Pamela Krueger. Regeneron ... protein A binding. ... Krueger is Associate Director at Regeneron Pharmaceuticals.
Combinatorial Inhibition of Myostatin and Activin A Improves ... - Wiley
Ashique Rafique and Pamela Krueger are employees of Regeneron Pharmaceuticals Inc. Catherine L. Omosule, Dominique Joseph, Brooke Weiler ...
A Mucin 16 bispecific T cell–engaging antibody for the treatment of ...
Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA. View all articles by this author. Pamela Krueger https://orcid.org/0000-0002-6166-7189.
A PD-1-targeted, receptor-masked IL-2 immunocytokine that ...
Protein production. All antibody or Fc/IL-2 fusion proteins and CD3 BsAbs were produced at Regeneron Pharmaceuticals. The proteins were ...
A Biparatopic Antibody–Drug Conjugate to Treat MET-Expressing ...
Pamela Krueger, Randi Foster, Zhaoyuan Chen, Marc W. ... Regeneron Pharmaceuticals, Inc., Tarrytown, New York. ... B, Western blots showing the levels of the ...
A PSMA-targeting CD3 bispecific antibody induces antitumor ...
Patients with hematological cancers have improved outcomes after treatment with bispecific antibodies that bind to CD3 on T cells and that redirect T cells ...
Dangshe Ma Regeneron · Department of Therapeutic Proteins
Dangshe MA, Research Director | Cited by 99 | of Regeneron, Tarrytown | Read 20 publications | Contact Dangshe MA.
Mice with megabase humanization of their immunoglobulin genes ...
... Pamela Krueger, Jeanette Fairhurst, David M ... protein-protein ... Conflict of interest statement: Several authors are employed by Regeneron Pharmaceuticals, Inc.
Generation of T‐cell‐redirecting bispecific antibodies with ... - Nature
complex (MHC) proteins, which interact with the T ... Ma, William Poueymirou, Pamela Krueger ... Regeneron Pharmaceuticals, Inc. has filed patent.
Shunhai Wang - Analytical Chemistry Group, Regeneron ... - AMiner
... Olivia Q. Antao,Yuetian Yan,Shunhai Wang, Willy Ramos,Pamela Krueger,Christina Adler. Cell Reports Medicinepp.101747, (2024). 引用0浏览0WOS 引用. 0. 0.
Inhibition of complement pathway activation with Pozelimab, a fully ...
... Pamela Krueger, Tammy Huang, William Poueymirou, Robert Babb, Michael P. ... and Regeneron Pharmaceuticals, Inc. is ... C5 proteins (with ...